![]() ![]() Finally, you can learn more about diabetes technology and criteria for accessing it here. You can also stay in the loop about our campaigning on this and other related issues here. There is still work to do, but today here at Diabetes UK, we are celebrating a clear step towards many more people living with all types of diabetes having access to the technologies that can help them lives happier and healthier lives with the condition. ![]() Please fill in this form to tell us about your experience trying to access Flash or CGM after your next diabetes appointment. Let us know how you get onĪfter your next appointment with your diabetes healthcare team if you asked about access to Flash or CGM we’d like to know how the conversation went. We’ll also monitor what’s happening, so we can make sure we’re helping you to navigate this change and that we’re supporting the NHS to get this right as well as we can. Not least by continuing to press the Government to prioritise diabetes care as the NHS tries to recover from the enormous impact of the coronavirus pandemic. The FreeStyle Libre 3 technology provides continuous, real-time glucose readings automatically delivered to smartphones 2 every minute, offering unsurpassed 14-day accuracy 1 in the smallest and thinnest 3 sensor design at the same affordable price 7 as previous versions of the device. We will of course be working to ensure this happens. It’s important to note that these guidelines have only been published today, meaning local areas will need some time to put them into practice. We know that many of you will understandably be keen to get access to Flash or CGM as soon as possible considering these new guidelines and we suggest that you speak to your diabetes team about this at your next appointment. See detail on what these tech recommendations and other guidelines are from across the UK. While NICE only provides recommendations for the NHS in England and Wales, we think that the health service across the UK should adopt these tech recommendations as the minimum standard. We are also pleased to see the new guidelines recommending that the health system addresses the inequalities in Flash and CGM access that already exist – something we called for them to do in our response to the consultation on these guidelines. some people with type 2 diabetes who use insulin intensive therapy (2 or more injections a day) should have access to Flash, for example if they experience recurrent or severe hypos, if they have a disability that means they cannot finger-prick test or if they would otherwise be advised to test 8 or more times a day.all children with type 1 diabetes should have access to CGM and that.all adults with type 1 diabetes should have access to either Flash or CGM.We’re thrilled that our response to their consultation and our wider work pushing for better access to Flash and CGM has been heard - including via our more recent Diabetes is Serious and Cheque for Tech campaigns. We have been campaigning for better access to these technologies for many years and has been actively involved in responding to NICE’s consultation on this guideline update. These new guidelines represent a shift towards a better understanding of technology as an integral part of diabetes management, rather than an added luxury. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |